Market Overview
The percutaneous coronary intervention (PCI) devices market is estimated at USD 10.02 billion in 2025 and is projected to reach USD 16.47 billion by 2034 at a CAGR of 5.68%. A key driver is the high prevalence of coronary artery disease, the most common heart disease, which is usually caused by plaque building up on the walls of the arteries that carry blood to the heart and partially narrowing them. Angina, the major symptom of coronary artery disease, includes chest pain and discomfort. Incidence in high-income countries rises with faulty lifestyles, high-fat diets, excessive alcohol consumption, and smoking.
Rising Demand for Minimally Invasive Care
Physicians are increasingly shifting toward minimally invasive procedures such as PCI to treat coronary artery disease. Obese and geriatric populations are especially prone to cardiac disease, and diabetes and sedentary lifestyles add to the risk, increasing PCI volumes. According to the CDC, about 30.3 million people in the US have diabetes, or 9.4% of the population, a figure the report says could fuel PCI use. In Canada, about 2.4 million people aged 20 years and above live with ischemic heart disease. In the European region, CVD causes more than half of the deaths, and in China, coronary heart disease is the second leading cause of cardiovascular deaths. Globalization, urbanization, diabetes, alcohol, tobacco, and inactivity all contribute to the growing number of coronary artery disease cases, which in turn lifts the adoption of PCI procedures.
Robotics Emerges as a Key Trend
Robotic-assisted PCI is expected to become a key industry trend. Robots perform interventions remotely through a system with two major components: a cockpit and a robotic arm. Benefits include reduced radiation exposure, enhanced ergonomics, improved precision, and potential for tele-stenting. Rising integration of AI, machine learning, and advanced imaging is expected to boost development, although high costs and technology constraints are hindering adoption. Corindus (Siemens Healthineers) offers the CorPath GRX system with U.S. FDA approval, Robocath develops the Robotic Angioplasty System, and Stereotaxis specializes in magnetic navigation systems for catheter guidance. Philips Healthcare offers the Azurion with FlexArm, combining advanced imaging with robotic assistance and AI-driven analytics for real-time decision support.
Procedure Settings and Challenges
Hospitals held the largest end-use share in 2024, owing to higher patient admissions and advanced technologies supporting minimally invasive procedures, trained professionals, and robotic devices performing PCI techniques. Hospitals are also equipped with advanced diagnostic and therapeutic systems, and tie-ups with reimbursement authorities such as Medicare and Medicaid increase their utilization. The end-use segmentation also includes catheterization labs and ambulatory surgical centers.
The market faces challenges from side effects associated with coronary intervention devices. During cardiac catheterization, possible complications include bleeding, infection, and pain at the insertion site, and potential damage if the catheter pokes a hole in a blood vessel. Allergies to local anesthesia and adverse reactions to contrast media are also cited, and the report lists product recalls as a restraint.
Regionally, North America was the largest market in 2024, accounting for more than 34.23% of the global market, while Asia Pacific is projected to grow at the fastest rate owing to technological advancements.
Browse In-depth Market Research Report:
Key Players in the PCI Devices Market
- Abbott
- Braun
- ASAHI INTECC Company Limited
- Biosensors International Group, Ltd.
- Boston Scientific Corporation
- R. Bard
- BIOTRONIK
- Comed BV
- Cook
- Meril Lifesciences
- Cordis
- Medtronic PLC
- Merit Medical System
- Terumo Corporation
Conclusion
The percutaneous coronary intervention (PCI) devices market, projected at USD 16.47 billion by 2034, is shaped by the burden of coronary artery disease, preference for minimally invasive procedures, and emerging robotic-assisted PCI platforms. Suppliers that address safety during cardiac catheterization and support hospital and catheterization labs workflows will be well placed as innovation continues.
More Trending Latest Reports By Polaris Market Research:
Antimicrobial Packaging Market
Endoscopy Visualization Systems Market
English
Spanish
Deutsch
Turkish
Italiano
Russian